Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

29.80
Delayed Data
As of May 29
 -0.47 / -1.55%
Today’s Change
11.34
Today|||52-Week Range
39.80
-22.70%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close30.27
Today’s open30.25
Day’s range28.59 - 30.71
Volume88,941
Average volume (3 months)70,148
Market cap$531.6M
Dividend yield2.24%
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+284.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales22.45
Price/Book4.58

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc-1.09-4.55%
VTLVital Therapies Inc+0.10+0.46%
SRNESorrento Therapeutic...-0.01-0.07%
TBPHTheravance Biopharma...-0.38-2.65%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$4.3M
Annual profit (last year)-$17.8M
Net profit margin-410.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers